Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutical Quantum Genomics to give an exclusive license for firibastat in Greater China region, including Hong Kong and Macao. Read the press realease Previous Post (p) Quantum Genomics Reports First Half 2020 Financial Results Next Post (n) Quantum Genomics to give an exclusive license for firibastat in Canada